We identified 10 interactors common to all three MS phenotypes – ABL1, GRB2, INPP5D, KIF1B, PIK3R1, PLCG1, PRKCD, SRC, TUBA1A and TUBA4A, and identified a number of common genes in drug signalling pathways. This evidence concerns the gene TUBA1A and myeloid sarcoma.